These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8453974)

  • 21. Coronary vascular K+ATP channels contribute to the maintenance of myocardial perfusion in dogs with pacing-induced heart failure.
    Yamamoto M; Egashira K; Arimura K; Tada H; Shimokawa H; Takeshita A
    Jpn Circ J; 2000 Sep; 64(9):701-7. PubMed ID: 10981856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of protection afforded by preconditioning to endothelial function against ischemic injury.
    Bouchard JF; Lamontagne D
    Am J Physiol; 1996 Nov; 271(5 Pt 2):H1801-6. PubMed ID: 8945894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of K+ATP channel and adenosine receptor blockade during rest and exercise in congestive heart failure.
    Traverse JH; Chen Y; Hou M; Li Y; Bache RJ
    Circ Res; 2007 Jun; 100(11):1643-9. PubMed ID: 17478726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glibenclamide antagonizes adenosine A1 receptor-mediated cardioprotection in stunned canine myocardium.
    Yao Z; Gross GJ
    Circulation; 1993 Jul; 88(1):235-44. PubMed ID: 8319338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent coronary vasodilation during long-term, supramaximal doses of adenosine.
    Crystal GJ; Downey HF; Bashour FA
    Am J Physiol; 1984 Nov; 247(5 Pt 2):H869-73. PubMed ID: 6496766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasodepressor mechanisms of 2-(1-octynyl)-adenosine (YT-146), a selective adenosine A2 receptor agonist, involve the opening of glibenclamide-sensitive K+ channels.
    Yoneyama F; Yamada H; Satoh K; Taira N
    Eur J Pharmacol; 1992 Mar; 213(2):199-204. PubMed ID: 1521559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of hypoxia-induced relaxation of rabbit isolated coronary arteries by NG-monomethyl-L-arginine but not glibenclamide.
    Jiang C; Collins P
    Br J Pharmacol; 1994 Mar; 111(3):711-6. PubMed ID: 8019749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tilisolol hydrochloride dilates coronary arteries through an ATP-sensitive K(+)-channel opening mechanism in dogs.
    Liu Q; Nakae I; Takahashi M; Takaoka A; Kinoshita M
    Cardiovasc Drugs Ther; 1996 Mar; 10(1):23-30. PubMed ID: 8723167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct in vivo observation of subendocardial arteriolar response during reactive hyperemia.
    Yada T; Hiramatsu O; Kimura A; Tachibana H; Chiba Y; Lu S; Goto M; Ogasawara Y; Tsujioka K; Kajiya F
    Circ Res; 1995 Sep; 77(3):622-31. PubMed ID: 7641332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ATP-sensitive potassium channel inhibition on coronary metabolic vasodilation in humans.
    Farouque HM; Worthley SG; Meredith IT
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):905-10. PubMed ID: 15016638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence against KATP channel involvement in adenosine receptor-mediated dilation of epicardial vessels.
    Makujina SR; Olanrewaju HA; Mustafa SJ
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H716-24. PubMed ID: 8067427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation.
    Aversano T; Ouyang P; Silverman H
    Circ Res; 1991 Sep; 69(3):618-22. PubMed ID: 1651815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of A(2A)-adenosine receptor activation for ATP-mediated coronary vasodilation in guinea-pig isolated heart.
    Erga KS; Seubert CN; Liang HX; Wu L; Shryock JC; Belardinelli L
    Br J Pharmacol; 2000 Jul; 130(5):1065-75. PubMed ID: 10882391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glibenclamide attenuates adenosine-induced bradycardia and coronary vasodilatation.
    Belloni FL; Hintze TH
    Am J Physiol; 1991 Sep; 261(3 Pt 2):H720-7. PubMed ID: 1909503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of the ATP-dependent potassium channel antagonist, glyburide, on coronary blood flow and susceptibility to ventricular fibrillation in unanesthetized dogs.
    Billman GE; Avendano CE; Halliwill JR; Burroughs JM
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):197-204. PubMed ID: 7679152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac versus coronary vasodilator actions of isobutylmethylxanthine in dogs: comparison with theophylline.
    Takahashi K; Wada Y; Taira N
    Jpn J Pharmacol; 1986 May; 41(1):23-32. PubMed ID: 2426501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glyburide inhibits dipyridamole-induced forearm vasodilation but not adenosine-induced forearm vasodilation.
    Bijlstra P; van Ginneken EE; Huls M; van Dijk R; Smits P; Rongen GA
    Clin Pharmacol Ther; 2004 Mar; 75(3):147-56. PubMed ID: 15001965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of adenosine A(2A) and A(2B) receptors to ischemic coronary dilation: role of K(V) and K(ATP) channels.
    Berwick ZC; Payne GA; Lynch B; Dick GM; Sturek M; Tune JD
    Microcirculation; 2010 Nov; 17(8):600-7. PubMed ID: 21044214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenosine A(2A) receptors mediate coronary microvascular dilation to adenosine: role of nitric oxide and ATP-sensitive potassium channels.
    Hein TW; Belardinelli L; Kuo L
    J Pharmacol Exp Ther; 1999 Nov; 291(2):655-64. PubMed ID: 10525085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glibenclamide, a specific inhibitor of ATP-sensitive K+ channels, inhibits coronary vasodilation induced by angiotensin II-receptor antagonists.
    Tada H; Egashira K; Yamamoto M; Ueno H; Takemoto M; Shimokawa H; Takeshita A
    J Cardiovasc Pharmacol; 1997 Sep; 30(3):313-9. PubMed ID: 9300314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.